Today, UPMC discussed the plans to effectively and equitably administer the new AstraZeneca Evusheld to eligible patients. This two-drug product using monoclonal antibodies is authorized… Read more
Posted by newsbureau
Today, UPMC discussed the plans to effectively and equitably administer the new AstraZeneca Evusheld to eligible patients. This two-drug product using monoclonal antibodies is authorized… Read more